Disc Medicine, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$236.0 | -$129.7 | -$91.1 | -$47.5 | -$30.9 |
| Net income | -$212.2 | -$109.4 | -$76.4 | -$46.8 | -$36.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$181.3 | -$94.4 | -$73.6 | -$42.4 | -$27.6 |
| Dividends | — | — | — | — | $0.0 |
Shares outstanding 38.4M · Free float 43.1%
Annual filing data through FY ended December 31, 2025; float as of October 5, 2026.